All Stories

  1. Clonal Hematopoiesis in Cardiovascular Risk: Focus on Inflammatory Mechanisms
  2. Inflammatory Bowel Disease-induced Inflammation Augments Clonal Hematopoiesis of Indeterminate Potential through Ref-1
  3. Human plasma proteomic profile of clonal hematopoiesis
  4. JAK2-mutant clonal hematopoiesis is associated with venous thromboembolism
  5. Sequence variants influencing the regulation of serum IgG subclass levels
  6. Clonal Hematopoiesis of Indeterminate Potential With Loss of Tet2 Enhances Risk for Atrial Fibrillation Through Nlrp3 Inflammasome Activation
  7. Risk factors for clonal hematopoiesis of indeterminate potential in people with HIV: a report from the REPRIEVE trial
  8. Functional and molecular profiling of hematopoietic stem cells during regeneration
  9. Genetic modification of inflammation- and clonal hematopoiesis–associated cardiovascular risk
  10. Long-term longitudinal analysis of 4,187 participants reveals new insights into determinants of incident clonal hematopoiesis
  11. Clonal Hematopoiesis and Risk of Incident Lung Cancer
  12. Author Correction: Functional dissection of inherited non-coding variation influencing multiple myeloma risk
  13. Genetic modification of inflammation and clonal hematopoiesis-associated cardiovascular risk
  14. Germline genomic and phenomic landscape of clonal hematopoiesis in 323,112 individuals
  15. Mendelian randomization supports bidirectional causality between telomere length and clonal hematopoiesis of indeterminate potential
  16. Clonal Hematopoiesis Is Associated With Higher Risk of Stroke
  17. Association of clonal hematopoiesis with chronic obstructive pulmonary disease
  18. Functional dissection of inherited non-coding variation influencing multiple myeloma risk
  19. Dnmt3a-mutated clonal hematopoiesis promotes osteoporosis
  20. Distinction of lymphoid and myeloid clonal hematopoiesis
  21. Association of Diet Quality With Prevalence of Clonal Hematopoiesis and Adverse Cardiovascular Events
  22. ZBTB33 Is Mutated in Clonal Hematopoiesis and Myelodysplastic Syndromes and Impacts RNA Splicing
  23. Association of Clonal Hematopoiesis With Incident Heart Failure
  24. Prognostic implications of troponin T variations in inherited cardiomyopathies using systems biology
  25. Germline variants at SOHLH2 influence multiple myeloma risk
  26. HLA Class I Genotypes with Predicted Strong Binding Affinity to Mutated NPM1 Are Associated with Lower Relapse Risk in Matched Related or Unrelated Transplant for NPM1 Mutated Acute Myeloid Leukemia
  27. Accelerating target deconvolution for therapeutic antibody candidates using highly parallelized genome editing
  28. Premature Menopause, Clonal Hematopoiesis, and Coronary Artery Disease in Postmenopausal Women
  29. S100A6 is a critical regulator of hematopoietic stem cells
  30. Identification of germline variants in adults with hemophagocytic lymphohistiocytosis
  31. ProTstab – predictor for cellular protein stability
  32. MPRAscore: robust and non-parametric analysis of massively parallel reporter assays
  33. How good are pathogenicity predictors in detecting benign variants?
  34. How good are pathogenicity predictors in detecting benign variants?
  35. The multiple myeloma risk allele at 5q15 lowers ELL2 expression and increases ribosomal gene expression
  36. PON-tstab: Protein Variant Stability Predictor. Importance of Training Data Quality
  37. Working toward precision medicine: Predicting phenotypes from exomes in the Critical Assessment of Genome Interpretation (CAGI) challenges
  38. Performance of in silico tools for the evaluation of p16INK4a (CDKN2A) variants in CAGI
  39. Predicting Severity of Disease-Causing Variants
  40. Variation Interpretation Predictors: Principles, Types, Performance, and Choice
  41. PON-Sol: prediction of effects of amino acid substitutions on protein solubility
  42. PON-mt-tRNA: a multifactorial probability-based method for classification of mitochondrial tRNA variations
  43. Classification of Amino Acid Substitutions in Mismatch Repair Proteins Using PON-MMR2
  44. Harmful somatic amino acid substitutions affect key pathways in cancers
  45. PON-P2 for predicting pathogenicity of non-synonymous variations